Canine status epilepticus: A translational platform for human therapeutic trials

Epilepsia

Volumn 52, Issue SUPPL. 8, 2011, Pages 31-34

  Leppik, Ilo E ^a,b   Patterson, Edward N ^c   Coles, Lisa D ^a   Craft, Elise M ^c   Cloyd, James C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Canine epilepsy; Status epilepticus; Translational platform

Indexed keywords

DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; PHENOBARBITAL; PHENYTOIN; PLACEBO;

ANIMAL MODEL; AREA UNDER THE CURVE; CLINICAL FEATURE; CONFERENCE PAPER; CONTINUOUS INFUSION; DOG; DRUG BLOOD LEVEL; DRUG EFFICACY; EPILEPTIC STATE; LOADING DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; PHENYTOIN; PILOT PROJECTS; PIRACETAM; REPRODUCIBILITY OF RESULTS; STATUS EPILEPTICUS;

EID: 80053590410     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03231.x     Document Type: Conference Paper

References (14)

1. Bateman SW, Parent JM,. (1999) Clinical findings, treatment and outcome with acute status epilepticus or cluster seizures: 156 cases (1990-1995). J Am Vet Med Assoc 215: 1463-1468. (Pubitemid 129536058)
2. Berendt M, Høgenhaven H, Flagstad A, Dam M,. (1999) Electroencephalography in dogs with epilepsy: similarities between human and canine findings. Acta Neurol Scand 99: 276-283. (Pubitemid 29202184)
3. Craft EM, Patterson EE, Coles LD, Leppik IE, Cloyd JC,. (2011) Pharmacokinetics and tolerability of intravenous fosphenytoin in four health dogs. J Vet Int Med 25: 726. [Abstract N727.]
4. Cranford RE, Leppik IE, Patrick B, Anderson CB, Kostick B,. (1978) Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology 28: 874-880. (Pubitemid 8390039)
5. DeLorenzo R,. (2006) Incidence and cases of status epilepticus. In, Wasterlain CG, Treiman DM, (Eds) In status epilepticus: mechanisms and management. MIT Press, Cambridge Mass and London, pp. 17-32.
6. Kalviainen R,. (2007) Status epilepticus treatment guidelines. Epilepsia 48: 99-102. (Pubitemid 350045540)
7. Leppik IE,. (1998) AED doses: from animals to humans. Adv Neurol 76: 89-93.
8. Leppik IE, Boucer BA, Wilder BJ, Murthy VS, Watridge C, Graves NM, Rangel RJ, Rask CA, Turlapaty P,. (1990) Pharmacokinetics and safety of a phenytoin prodrug given IV or IM in patients. Neurology 40: 456-460. (Pubitemid 20117528)
9. Licht BG, Licht MH, Harper KM, Lin S, Curtin JJ, Hyson LL, Willard K., (2002) Clinical presentations of naturally occurring canine seizures: similarities to human seizures. Epilepsy Behav 3: 460-470. (Pubitemid 35460416)
10. Pitkänen A, Mathiesen C, Rønn LC, Møller A, Nissinen J,. (2007) Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat. Epilepsy Res 74: 45-54. (Pubitemid 46413707)
11. Platt SR, Hagg M,. (2002) Canine status epilepticus: a retrospective study of 50 cases. J Small Anim Pract 43: 151-153. (Pubitemid 135746983)
12. Saito M, Munana KR, Sharp NJ, Olby N,. (2001) Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effect of status epilepticus on outcome 3 and survival time: 32 cases (1990-1996). J Am Vet Med Assoc 219: 618-623. (Pubitemid 32801510)
13. Sloviter RS, Zappone CA, Bumanglag AV, Norwood BA, Kudrimoti H,. (2007) On the relevance of prolonged convulsive status epilepticus in animals to the etiology and neurobiology of human temporal lobe epilepsy. Epilepsia 48: 6-10. (Pubitemid 350045511)
14. Treiman DM, Meyers PD, Walton NY, et al., (1998) A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 339: 792-798. (Pubitemid 28447452)